Home > Financial Ratios > BIOCON

BIOCON
Working Capital/Sales

    Back to All Ratios
BIOCON is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
COMMUNITY POLL
for BIOCON
Please provide your vote to see the results

BIOCON Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Working Capital/Sales(x) 5.477.86-83.122.951.80

What is the latest Working Capital/Sales ratio of BIOCON ?

The latest Working Capital/Sales ratio of BIOCON is 5.47 based on Mar2026 Consolidated results.
Year Working Capital/Sales
Mar20265.47
Mar20257.86
Mar2024-83.12
Mar20232.95
Mar20221.80

How is Working Capital/Sales of BIOCON Trending?

Years Working Capital/Sales % Change
Mar2026 5.47
-30.41
Mar2025 7.86
Positive
Mar2024 -83.12
Negative
Mar2023 2.95
63.89
Mar2022 1.8 -

Other Financial Ratios of BIOCON


Compare Working Capital/Sales ratio of peers of BIOCON

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BIOCON ₹65,391.7 Cr -3.9% -5.1% 12.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹463,180.0 Cr 1.6% -1% 22.2% Stock Analytics
DIVIS LABORATORIES ₹243,302.0 Cr 1.7% 10.1% 49.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹188,623.0 Cr 1.5% -1.2% 38.2% Stock Analytics
CIPLA ₹114,554.0 Cr 0.7% -3.5% -10.4% Stock Analytics
DR REDDYS LABORATORIES ₹97,741.0 Cr -1.3% 0.1% -7.8% Stock Analytics


BIOCON Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BIOCON

-3.9%

-5.1%

12.9%

SENSEX

-0.9%

-1.5%

-5.8%


You may also like the below Video Courses